Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT06715345

Efficacy and Safety of Novosis Putty for Degenerative Lumbar Disease

Conditions: Degenerative Lumbar Diseases

Sex: All
Ages: 22 Years – 80 Years
Healthy volunteers: No
Phase: NA
Enrollment: 48
Sponsor: CGBio Inc.

Location: The Catholic University of Korea, Eunpyeong St. Mary's Hospital Seoul

Summary

This clinical study aims to evaluate the efficacy and safety of NOVOSIS PUTTY for bone fusion in patients requiring posterior instrumentation and transforaminal lumbar interbody fusion (TLIF) due to degenerative lumbar disease.

Eligibility Criteria

Inclusion Criteria: * Adult aged ≥ 22 to ≤ 80 years * Subjects whose skeletal maturation are confirmed by showing the result of Risser stage 5 in Risser classification, the Plain Radiography * Subjects diagnosed with disc degeneration in the single level (L2-S1) lumbar spine along with spondylolisthesis of Meyerding grade 1 (degree of translocation: 0- \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06715345). StuddyBuddy aggregates publicly available trial information.